Expression of cytotoxic t-Lymphocyte antigen 4 on cd4+ and cd8+ t cells is increased in acute lung injury

DNA and Cell Biology

Volumn 32, Issue 12, 2013, Pages 722-726

  Zhou, Yujia ^a   Tang, Lunxian ^b   Lin, Minjia ^b   Xu, Shumin ^b   Bai, Jianwen ^b   Song, Haihan ^b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ACUTE LUNG INJURY; ADULT; AGED; ANTIGEN EXPRESSION; APACHE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FLOW CYTOMETRY; GENETIC ASSOCIATION; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATHOGENESIS; PRIORITY JOURNAL; UPREGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SMOKING;

ACUTE LUNG INJURY; AGED; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CTLA-4 ANTIGEN; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; SMOKING;

EID: 84888609752     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2112     Document Type: Article

References (26)

1. Adeniji, K., and Steel, A.C. (2012). The pathophysiology of perioperative lung injury. Anesthesiol Clin 30, 573-590.
2. Evans, D.B., Lee, J.E., Pisters, P.W., Charnsangavej, C., Ellis, L.M., Chiao, P.J., Lenzi, R., and Abbruzzese, J.L. (1997). Advances in the diagnosis and treatment of adenocarcinoma of the pancreas. Cancer Treat Res 90, 109-125.
3. Gajewski, T.F., Meng, Y., and Harlin, H. (2006). Immune suppression in the tumor microenvironment. J Immunother 29, 233-240. (Pubitemid 44297291)
4. Greenwald, R.J., Oosterwegel, M.A., van der Woude, D., Kubal, A., Mandelbrot, D.A,. Boussiotis, V.A., and Sharpe, A.H. (2002). CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol 32, 366-373. (Pubitemid 34173328)
5. Hadinia, A., Hossieni, S.V., Erfani, N., Saberi-Firozi, M., Fattahi, M.J., and Ghaderi, A. (2007). CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. J Gastroenterol Hepatol 22, 2283-2287. (Pubitemid 350145629)
6. Hiraoka, N., Onozato, K., Kosuge, T., and Hirohashi, S. (2006).Prevalence of FOXP3 + regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12, 5423-5434. (Pubitemid 44497257)
7. Hodi, F.S., Mihm, M.C., Soiffer, R.J., Haluska, F.G., Butler, M., Seiden, M.V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., Padera, R., Jaklitsch, M.T., Shankar, S., Chen, T.C.,Korman, A., Allison, J.P., and Dranoff, G. (2003). Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA 100, 4712-4717. (Pubitemid 36457795)
8. Hotchkiss, R.S., Tinsley, K.W., Swanson, P.E., Schmieg, R.E., Hui, J.J., Chang, K.C., et al. (2001). Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+T lymphocytes in humans. J Immunol 166, 6952-6963. (Pubitemid 32467243)
9. Krummel, M.F., and Allison, J.P. (1996). CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183, 2533-2540. (Pubitemid 26192363)
10. Leach, D.R., Krummel, M.F., and Allison, J.P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271, 1734-1736. (Pubitemid 26102823)
11. Ligers, A., Teleshova, N., Masterman, T., Huang, W.X., and Hillert, J. (2001). CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2, 145-152. (Pubitemid 33674879)
12. Liu, Y., He, Z., Feng, D., Shi, G., Gao, R., Wu, X., Song, W., and Yuan, W. (2011). Cytotoxic T-lymphocyte Antigen-4 Polymorphisms and Susceptibility to Osteosarcoma. DNA Cell Biol 30, 1051-1055.
13. Liyanage U.K., Goedegebuure, P.S., Moore, T.T., Viehl, C.T., Moo-Young, T.A., Larson, J.W., Frey, D.M., Ehlers, J.P., Eberlein, T.J., and Linehan, D.C. (2006). Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinoma. J Immunother 29, 416-424. (Pubitemid 44288954)
14. Loos, M., Giese, N.A., Kleeff, J., Giese, T., Gaida, M.M., Bergmann, F., Laschinger, M., W Bü chler, M., and Friess, H. (2008). Clinical significance and regulation of the costimulatory molecule B7-H1 in pancreatic cancer. Cancer Lett 268, 98-109.
15. Mohammed, K.A., Nasreen, N., Ward, M.J., and Antony, V.B. (2000). Induction of acute pleural inflammation by Staphylococcus aureus. I. CD4+ T cells play a critical role in experimental empyema. J Infect Dis 181, 1693-1699. (Pubitemid 30387762)
16. Nakajima, T., Suarez, C.J., Lin, K.W., Jen, K.Y., Schnitzer, J.E., Makani, S.S., Parker, N., Perkins, D.L., and Finn, P.W. (2013). T cell pathways involving CTLA4 contribute to a model of acute lung injury. J Immunol 184, 5835-5841.
17. Nishikawa, H., Kato, T., Tawara, I., Takemitsu, T., Saito, K., Wang, L., Ikarashi, Y., Wakasugi, H., Nakayama, T., Taniguchi, M., Kuribayashi, K., Old, L.J., and Shiku, H. (2005). Accelerated chemically induced tumor development mediated by CD4 + CD25 + regulatory T cells in wild-type hosts. Proc Natl Acad Sci USA 102, 9253-9257. (Pubitemid 40923550)
18. Oosterwegel, M.A., Greenwald, R.J., Mandelbrot, D.A., Lorsbach, R.B., and Sharpe, A.H. (1999). CTLA-4 and T cell activation. Curr Opin Immunol 11, 294-300. (Pubitemid 29263957)
19. Royal, R.E., Levy, C., Turner, K., Mathur, A., Hughes, M., Kammula, U.S., Sherry, R.M., Topalian, S.L., Yang, J.C., Lowy, I., and Rosenberg, S.A. (2010). Phase 2 trial of single agent Ipilimumab (anti-CTLA-4) for locally advanced or metastatic pancreatic adenocarcinoma. J Immunother 33, 828-833.
20. Schwulst, S.J., Muenzer, J.T., Chang, K.C., Brahmbhatt, T.S., Coopersmith, C.M., and Hotchkiss, R.S. (2008). Lymphocyte phenotyping to distinguish septic from nonseptic critical illness. J Am Coll Surg 206, 335-342.
21. Stephens, R.S., Shah, A.S., and Whitman, G.J. (2013). Lung injury and acute respiratory distress syndrome after cardiac surgery. Ann Thorac Surg 95, 1122-1129.
22. Sun, T., Zhou, Y., Yang, M., Hu, Z., Tan,W., Han, X., Shi, Y., Yao, J., Guo, Y., Yu, D., Tian, T., Zhou, X., Shen, H., and Lin, D. (2008). Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 68, 7025-7034.
23. Tivol, E.A., Borriello, F., Schweitzer, A.N., Lynch, W.P., Bluestone, J.A., and Sharpe, A.H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
24. Tolle, L.B., and Standiford, T.J. (2013). Danger-associated molecular patterns (DAMPs) in acute lung injury. J Pathol 229, 145-156.
25. Ueda, H., Howson, J.M., Esposito, L., Heward, J., Snook, H., Chamberlain, G., et al. (2003). Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506-511. (Pubitemid 36648570)
26. von Dossow-Hanfstingl, V. (2012). Advances in therapy for acute lung injury. Anesthesiol Clin 30, 629-639.